Literature DB >> 21837451

Multicentric Castleman's disease as a cause for unclear febrile episodes in a 55-year-old HIV-infected man.

H Lederer1, Y Achermann, M Tinguely, F Stenner, J Fehr.   

Abstract

Our case illustrates the difficulties involved in diagnosing multicentric Castleman's disease (MCD) in a human immunodeficiency virus-infected man with febrile episodes and malaise. In the absence of well-established treatment protocols, we have chosen a new treatment algorithm with rituximab, etoposide, and valganciclovir, which led to the remission of clinical symptoms. Yet, we advocate focused exploration for MCD in immunosuppressed patients with unclear febrile episodes, as recent advances in treatment are promising.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21837451     DOI: 10.1007/s15010-011-0174-9

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Case records of the Massachusetts General Hospital: Case No. 40231.

Authors:  B CASTLEMAN; V W TOWNE
Journal:  N Engl J Med       Date:  1954-06-10       Impact factor: 91.245

Review 2.  Fifty years of multicentric Castleman's disease.

Authors:  Ashita Waterston; Mark Bower
Journal:  Acta Oncol       Date:  2004       Impact factor: 4.089

3.  High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

Authors:  E Oksenhendler; G Carcelain; Y Aoki; E Boulanger; A Maillard; J P Clauvel; F Agbalika
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

4.  Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease.

Authors:  Mark Bower; Tom Newsom-Davis; Kikkeri Naresh; Shairoz Merchant; Belinda Lee; Brian Gazzard; Justin Stebbing; Mark Nelson
Journal:  J Clin Oncol       Date:  2011-05-09       Impact factor: 44.544

5.  Treatment of HIV-associated multicentric Castleman's disease with oral etoposide.

Authors:  D Scott; L Cabral; W J Harrington
Journal:  Am J Hematol       Date:  2001-02       Impact factor: 10.047

6.  The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease.

Authors:  T Powles; J Stebbing; A Bazeos; E Hatzimichael; S Mandalia; M Nelson; B Gazzard; M Bower
Journal:  Ann Oncol       Date:  2009-01-29       Impact factor: 32.976

Review 7.  Multicentric Castleman's disease in HIV infection: a systematic review of the literature.

Authors:  Eleni E Mylona; Ioannis G Baraboutis; Lazaros J Lekakis; Ourania Georgiou; Vasilios Papastamopoulos; Athanasios Skoutelis
Journal:  AIDS Rev       Date:  2008 Jan-Mar       Impact factor: 2.500

8.  Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.

Authors:  Corey Casper; Elizabeth M Krantz; Lawrence Corey; Steven R Kuntz; Jie Wang; Stacy Selke; Shannon Hamilton; Meei-Li Huang; Anna Wald
Journal:  J Infect Dis       Date:  2008-07-01       Impact factor: 5.226

9.  Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.

Authors:  Laurence Gérard; Alice Bérezné; Lionel Galicier; Véronique Meignin; Martine Obadia; Nathalie De Castro; Christine Jacomet; Renaud Verdon; Isabelle Madelaine-Chambrin; Emmanuelle Boulanger; Sylvie Chevret; Felix Agbalika; Eric Oksenhendler
Journal:  J Clin Oncol       Date:  2007-08-01       Impact factor: 44.544

Review 10.  HIV-associated multicentric Castleman disease.

Authors:  Eric Oksenhendler
Journal:  Curr Opin HIV AIDS       Date:  2009-01       Impact factor: 4.283

  10 in total
  2 in total

1.  Spontaneous pulmonary hypertension in genetic mouse models of natural killer cell deficiency.

Authors:  Matthew T Rätsep; Stephen D Moore; Salema Jafri; Melissa Mitchell; Hugh J M Brady; Ofer Mandelboim; Mark Southwood; Nicholas W Morrell; Francesco Colucci; Mark L Ormiston
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-09-20       Impact factor: 5.464

2.  Episodic fevers and vasodilatory shock mimicking urosepsis in a patient with HIV-associated multicentric Castleman's Disease: a case report.

Authors:  Stephanie Anderson; Sarah C Sasson; Frederick J Lee; Wendy Cooper; Stephen Larsen; Roger Garsia
Journal:  BMC Infect Dis       Date:  2016-02-01       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.